← Back to all trials
Active Not Recruiting
NCT05608577
RE-BLEED: A Digital Platform for Identifying Bleeding Patients - a Feasibility Study
Conditions: Hemorrhage, Trauma, Gastro Intestinal Bleeding
Sex: All
Ages: 16 Years – 110 Years
Enrollment: 200
Sponsor: University of Oxford
Location: United Kingdom
Summary
The RE-BLEED feasibility study aims to develop and test a real-time digital platform, whereby bleeding patients in-hospital can be identified and approached for their consent to participate in future research studies.
Eligibility Criteria
Inclusion Criteria:Retrospective cohort:Adults aged between 16 and 110Admitted to hospital (Oxford University Hospitals NHS Foundation Trust) or attended the emergency department between 1/3/2011 to 31/8/2023Prospective cohort:Adults aged between 16 and 110Admitted to hospital (Oxford University Hospitals NHS Foundation Trust) or attended the emergency department between 1/10/2021 to 31/8/2023Exclusion Criteria:Both retrospective and prospective cohorts:Patients who inform us directly that they do not wish their records used in this research studyPatients who have completed the NHS Opt-out.
Source: ClinicalTrials.gov (NCT05608577). StuddyBuddy aggregates publicly available trial information.
